![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Davidson Michael H
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.3, Iss.6, 2004-11, pp. : 547-557
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The US Government Accountability Office is to review a drug approval process used by the FDA
Inpharma, Vol. 1, Iss. 1633, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By van Ahlen H Zumbé J Stauch K Landen H
The Journal of International Medical Research, Vol. 33, Iss. 3, 2005-05 ,pp. :